Dana Farber Cancer Institute Site Number : 8400101

Boston, Massachusetts 02115

0 studies enrolling now · 1 studies all time

What they study most

Malignant Solid Tumor

Studies at this site

• A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors — Completed